Magnetic Nanoscalpel for the Effective Treatment of Ascites Tumors.
DNA aptamers
apoptosis
ascitic tumor
magnetic nanodisks
magneto-mechanical therapy
necrosis
“smart nanoscalpel”
Journal
Journal of functional biomaterials
ISSN: 2079-4983
Titre abrégé: J Funct Biomater
Pays: Switzerland
ID NLM: 101570734
Informations de publication
Date de publication:
24 Mar 2023
24 Mar 2023
Historique:
received:
02
03
2023
revised:
16
03
2023
accepted:
22
03
2023
medline:
27
4
2023
pubmed:
27
4
2023
entrez:
27
4
2023
Statut:
epublish
Résumé
One of the promising novel methods for radical tumor resection at a single-cell level is magneto-mechanical microsurgery (MMM) with magnetic nano- or microdisks modified with cancer-recognizing molecules. A low-frequency alternating magnetic field (AMF) remotely drives and controls the procedure. Here, we present characterization and application of magnetic nanodisks (MNDs) as a surgical instrument ("smart nanoscalpel") at a single-cell level. MNDs with a quasi-dipole three-layer structure (Au/Ni/Au) and DNA aptamer AS42 (AS42-MNDs) on the surface converted magnetic moment into mechanical and destroyed tumor cells. The effectiveness of MMM was analyzed on Ehrlich ascites carcinoma (EAC) cells in vitro and in vivo using sine and square-shaped AMF with frequencies from 1 to 50 Hz with 0.1 to 1 duty-cycle parameters. MMM with the "Nanoscalpel" in a sine-shaped 20 Hz AMF, a rectangular-shaped 10 Hz AMF, and a 0.5 duty cycle was the most effective. A sine-shaped field caused apoptosis, whereas a rectangular-shaped field caused necrosis. Four sessions of MMM with AS42-MNDs significantly reduced the number of cells in the tumor. In contrast, ascites tumors continued to grow in groups of mice and mice treated with MNDs with nonspecific oligonucleotide NO-MND. Thus, applying a "smart nanoscalpel" is practical for the microsurgery of malignant neoplasms.
Identifiants
pubmed: 37103269
pii: jfb14040179
doi: 10.3390/jfb14040179
pmc: PMC10145876
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : the Regional State Autonomous Institution "Krasnoyarsk Regional Fund for Support of Scientific and Scientific and Technical Activities", Competition of scientific, technical and innovative projects in the interests of the first world-class climate scienti
ID : 2022060108781
Références
Nucleic Acid Ther. 2017 Apr;27(2):105-114
pubmed: 27923103
World J Gastrointest Surg. 2012 Apr 27;4(4):87-95
pubmed: 22590662
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Nucleic Acid Ther. 2022 Dec;32(6):497-506
pubmed: 35921069
RSC Adv. 2020 Feb 25;10(14):8161-8171
pubmed: 35558340
Gynecol Oncol. 2017 Sep;146(3):491-497
pubmed: 28624153
Sci Rep. 2017 Sep 7;7(1):10919
pubmed: 28883430
Nature. 1990 Aug 30;346(6287):818-22
pubmed: 1697402
Int J Mol Sci. 2022 Sep 14;23(18):
pubmed: 36142615
Int J Mol Sci. 2019 Feb 22;20(4):
pubmed: 30813239
Nanoscale. 2018 Dec 7;10(45):21414-21424
pubmed: 30427036
Nat Mater. 2010 Feb;9(2):165-71
pubmed: 19946279
Molecules. 2022 Jan 07;27(2):
pubmed: 35056696
Angew Chem Int Ed Engl. 2007;46(8):1222-44
pubmed: 17278160
Oncotarget. 2016 Mar 22;7(12):13446-63
pubmed: 26863567
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Sci Rep. 2017 Jun 26;7(1):4257
pubmed: 28652596
Toxicol Pathol. 2007 Jun;35(4):495-516
pubmed: 17562483
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Int J Mol Sci. 2020 Apr 17;21(8):
pubmed: 32316469
Clin Ther. 2016 Jul;38(7):1551-66
pubmed: 27158009
J Control Release. 2010 Feb 15;141(3):320-7
pubmed: 19874859
Int J Mol Sci. 2021 Sep 07;22(18):
pubmed: 34575825
Cancers (Basel). 2020 Jan 15;12(1):
pubmed: 31952299
Nanoscale Adv. 2020 Jun 19;2(9):3632-3655
pubmed: 36132753